Response: An Economic Evaluation of Iron Isomaltoside 1000 Versus Ferric Carboxymaltose in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia in Denmark
Crossref DOI link: https://doi.org/10.1007/s12325-019-00993-8
Published Online: 2019-06-01
Published Print: 2019-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pollock, Richard F. http://orcid.org/0000-0002-9873-7507
Muduma, Gorden
Text and Data Mining valid from 2019-06-01
Version of Record valid from 2019-06-01
Article History
Received: 10 May 2019
First Online: 1 June 2019